Novo Nordisk News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

27.03.15	MÄRKTE EUROPA/Erholungsbewegung kommt leicht ins Stocken (Dow Jones)
27.03.15	Novo Nordisk Plans To Resubmit NDAs Of Tresiba And Ryzodeg In US (RTTNews)
25.03.15	Novo Nordisk: Final Trials Of Faster-Acting Insulin Aspart Meet Primary Point (RTTNews)
24.03.15	Bristol-Myers Acquires License For Discovery Research Program From Novo Nordisk (RTTNews)
23.03.15	Novo Nordisk: Saxenda Approved In Europe To Treat Obesity (RTTNews)
02.02.15	Moody's: Pharmaceutical pipelines improve, but patent expiration exposure also edges higher (Moodys)
30.01.15	Novo Nordisk 2014 Profit Rises - Quick Facts (RTTNews)
23.01.15	ADXS In Focus, EGLT Soars, NEO Boosts Outlook, RMD Hits Record High (RTTNews)
22.01.15	Novo Nordisk Gets Positive CHMP Opinion For Obesity Drug Saxenda (RTTNews)
24.12.14	FDA Approves Novo Nordisk's Obesity Drug Saxenda (RTTNews)
12.09.14	U.S. FDA Panel Urges Approval Of Novo Nordisk Injection For Obesity (RTTNews)
02.09.14	Novo Nordisk Terminates R&D Activities Within Inflammatory Disorders (RTTNews)
07.08.14	Novo Nordisk H1 Profit Up - Quick Facts (RTTNews)
19.03.14	Novo Nordisk: First Phase 3 Trial With N8-GP Shows Positive Results (RTTNews)
24.12.13	FDA Approves Novo's Tretten For Rare Clotting Disorder (RTTNews)
20.12.13	Novo Nordisk Files Liraglutide For Regulatory Approval For Obesity (RTTNews)
10.12.13	Novo Nordisk Reported To Police For Violation Of Disclosure Obligation (RTTNews)
04.12.13	Moody's: Formulary exclusions credit negative for branded drug makers (Moodys)
31.10.13	Novo Nordisk 9-month Profit Rises - Quick Facts (RTTNews)
25.10.13	KORREKTUR/ROUNDUP: Europaweiter Rückruf für Insulinpräparat 'NovoMix 30' (dpa-afx)
25.10.13	ROUNDUP: Europaweiter Rückruf für Insulinpräparat 'NovoMix 30' (dpa-afx)
25.10.13	Rückruf für Chargen des Insulinpräparats 'NovoMix 30' von Novo Nordisk (Zus) (AWP)
25.10.13	Rückruf für Chargen des Insulinpräparats 'NovoMix 30' von Novo Nordisk (AF) (AWP)
25.10.13	ROUNDUP: Rückruf für Chargen des Insulinpräparats 'NovoMix 30' (dpa-afx)
25.10.13	Arzneimittelbehörde ruft Insulinpräparat zurück (dpa-afx)
25.10.13	Arzneimittelbehörde ruft Insulinpräparat von Novo Nordisk zurück (AWP)
10.10.13	Critical Alerts For Baidu.com, Home Depot, GenCorp, Novo Nordisk, and Silver Wheaton Released By InvestorsObserver (PR Newswire)
09.10.13	Drug Approvals, Data Presentations, Clinical Trials, New Appointments, and Corporate Events - Research Report on Johnson & Johnson, Novo Nordisk, Isis, Keryx, and The Medicines Company (PR Newswire)
30.09.13	Product Launches, Clinical Study Results, Historical Trials, Joint Lawsuits and Milestone Patient Enrollment - Research Report on Teva, Pacira, Novo Nordisk, Forest, and Amarin (PR Newswire)
08.08.13	Novo Nordisk Q2 Profit Climbs; Lifts FY13 Growth Forecast - Quick Facts (RTTNews)
07.08.13	Critical Alerts For Starbucks, Nordstrom, Novo Nordisk, MannKind, and Westport Innovations Released By InvestorsObserver (PR Newswire)
02.08.13	Novo Nordisk To Award $80,000 To Local Programs That Help People Living With Diabetes In Rochester, Minnesota As Part Of Educational Initiative (PR Newswire)
01.08.13	/K I L L K I L L K I L L - Novo Nordisk/ (PR Newswire)
01.08.13	Novo Nordisk To Award $80,000 To Local Programs That Help People Living With Diabetes In Seattle As Part Of Educational Initiative (PR Newswire)
11.02.13	Novo Nordisk: Keine US-Zulassung für Diabetes-Mittel (AWP)
11.02.13	Dow schliesst leicht im Minus -- SMI mit leichten Gewinnen -- Eurogruppe will keine Wechselkurse festlegen -- Deutsche Aktien verlieren -- Ermittlungen gegen Porsche-Aufsichtsräte (finanzen.ch)
05.12.12	Novo Nordisk A/S -- Moody's upgrades Novo Nordisk's rating to A1; stable outlook (Moodys)
30.01.12	INTERVIEW/Actavis-CEO will mit Insulin-Deal Branche aufmischen (Dow Jones)
08.02.10	inside-analytics.com / Die wöchentliche Top 10 der grössten Insidertransaktionen (Dow Jones)
29.05.09	Novo Nordisk: New study directly comparing insulin delivery devices shows that Next Generation FlexPen® has a significantly lower injection force than SoloStar® and KwikPen® (Businesswire)
11.09.08	Moody's: Europäische Pharmabranche vor grossen Herausforderungen - Generika (dpa-afx)
31.01.07	Novo Nordisk Announces Financial Statement for 2006 (PR Newswire)
18.04.06	Dana Haza Joins Novo Nordisk as Senior Director of the National Changing Diabetes Program (PR Newswire)
15.12.05	Neose and Novo Nordisk Expand Agreement (PR Newswire)
10.11.05	Novo Nordisk Becomes Insulin Market Leader (PR Newswire)
02.11.05	Novo Nordisk Appoints Christopher Porter as Director of Government Affairs in the United States (PR Newswire)
17.06.05	FDA Approves Levemir(R) (insulin detemir [rDNA Origin] Injection) - a New, Long-Acting Insulin Treatment for Diabetes (PR Newswire)
06.06.05	Winners of First Shock Society/Novo Nordisk Research Grant for Haemorrhagic Shock and Haemostasis are Announced (PR Newswire)
09.03.05	Novo Nordisk A/S AGM Statement (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Novo Nordisk (spons. ADRs)

Aktien Top/Flop

Novo Nordisk Peer Group Nachrichten

Meistgelesene Nachrichten